Serotonin Phase-shifts the Mouse Suprachiasmatic Circadian Clock In Vitro
The mammalian circadian clock in the suprachiasmatic nucleus (SCN) receives multiple afferent signals that could potentially modulate its phase. One input, the serotonin (5-HT) projection from the raphe nuclei, has been extensively investigated in rats and hamsters, yet its role(s) in modulating circadian clock phase remains controversial. To expand our investigation of 5-HT modulation of the SCN clock, we investigated the phase-shifting effects of 5-HT and its agonist, (+)8-hydroxy-2-(di-n-propylamino)tetralin (DPAT), when applied to mouse SCN brain slices. 5-HT induced 2–3 h phase advances when applied during subjective day, while non-significant phase shifts were seen after 5-HT application at other times. These phase shifts were completely blocked by the 5-HT antagonist, metergoline. DPAT also induced phase shifts when applied during mid-subjective day, and this effect appeared dose-dependent. Together, these results demonstrate that the mouse SCN, like that of the rat, is directly sensitive to in vitro phase-resetting by 5-HT.
Rebecca A. Prosser, Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro, Brain Research, Volume 966, Issue 1, 14 March 2003, Pages 110-115, ISSN 0006-8993, DOI: 10.1016/S0006-8993(02)04206-3. (http://www.sciencedirect.com/science/article/B6SYR-47RBRVD-H/2/a01fbb89d5e35d379606969ae6bb47fb)